Allied Healthcare Products Halted On A Circuit Breaker Down 30%
$AHPI
Industrial Specialties
Health Care
Allied Healthcare Products Halted On A Circuit Breaker Down 30%
Save time and jump to the most important pieces.
4 - ALLIED HEALTHCARE PRODUCTS INC (0000874710) (Issuer)
4 - ALLIED HEALTHCARE PRODUCTS INC (0000874710) (Issuer)
4 - ALLIED HEALTHCARE PRODUCTS INC (0000874710) (Issuer)
SC 13D/A - ALLIED HEALTHCARE PRODUCTS INC (0000874710) (Subject)
SC 13D/A - ALLIED HEALTHCARE PRODUCTS INC (0000874710) (Subject)
SC 13D/A - ALLIED HEALTHCARE PRODUCTS INC (0000874710) (Subject)
8-K - ALLIED HEALTHCARE PRODUCTS INC (0000874710) (Filer)
8-K - ALLIED HEALTHCARE PRODUCTS INC (0000874710) (Filer)
NT 10-Q - ALLIED HEALTHCARE PRODUCTS INC (0000874710) (Filer)
During Friday, 24 stocks hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Eastern Bankshares (NASDAQ:EBC). The smallest company by market cap to set a new 52-week low was Panbela Therapeutics (NASDAQ:PBLA). Bridger Aerospace Gr (NASDAQ:BAER)'s stock came under the most pressure, trading down 29.75% to reach a new 52-week low. FaZe Holdings (NASDAQ:FAZE) shares were the most resilient, as shares rose 0.93%, rebounding from its new 52-week low. The following stocks set new 52-week lows on Friday: Eastern Bankshares (NASDAQ:EBC) stock drifted down 10.52% on Friday morning to hit a new 52-week low of
Gainers Redhill Biopharma (NASDAQ:RDHL) stock rose 35.0% to $0.25 during Friday's pre-market session. The market value of their outstanding shares is at $22.6 million. Akanda (NASDAQ:AKAN) stock moved upwards by 29.1% to $0.36. The market value of their outstanding shares is at $12.3 million. Bionomics (NASDAQ:BNOX) shares increased by 19.54% to $5.26. The market value of their outstanding shares is at $39.5 million. Senti Biosciences (NASDAQ:SNTI) shares rose 13.66% to $2.08. The market value of their outstanding shares is at $91.2 million. TC BioPharm (Holdings) (NASDAQ:TCBP) stock increased by 13.15% to $6.45. The company's market cap stands at $256.3 million. AcelRx Pharmaceuticals